Department of Defence Tender by Dg Armed Forces Medical Service (GEM/2025/B/6030727)
Tab Dutasteride 0.5 mg
Tender Timeline
Tender Title: Tab Dutasteride 0.5 mg
Reference Number: GEM/2025/B/6030727
Issuing Authority
This tender is issued by the Department of Defence under the Ministry of Defence. The department is committed to ensuring the procurement of high-quality medical supplies to support the health and wellness of defence personnel.
Scope of Work and Objectives
The purpose of this tender is to solicit bids for the supply of Tab Dutasteride 0.5 mg. The total quantity to be supplied is 282,200 units. Suppliers are expected to adhere to strict quality and compliance standards, ensuring that all goods delivered meet the specifications outlined in this tender.
Eligibility Criteria
To be eligible to participate in this tender, bidders must be registered entities and comply with all relevant regulatory requirements. This includes holding valid licenses for pharmaceutical supply and meeting the minimum technical and financial standards as prescribed by the Department of Defence.
Technical Requirements
All products supplied must meet the specified technical requirements for Tab Dutasteride 0.5 mg. Bidders are required to submit documentation supporting their claims about the product’s efficacy, quality assurance protocols, and any relevant testing certifications.
Financial Requirements
Bidders must provide proof of financial stability, which may include bank statements or financial audits. An Earnest Money Deposit (EMD) will also be required, the specifics of which will be detailed in the tender documentation. Payment terms will be discussed with successful bidders once the evaluation process is complete.
Document Submission Details
All bid submissions should be made electronically through the designated portal as outlined in the tender documentation. All required supporting documents must be uploaded in the specified formats to avoid disqualification.
Special Provisions
This tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and startups. Special provisions may apply, promoting local manufacturing and compliance with Make in India policies.
Evaluation Process
Proposals will be evaluated based on criteria including adherence to technical specifications, price competitiveness, the quality of offered products, and the bidder's past performance. Successful bidders will be notified following the evaluation process.
Delivery Locations
The successful bidder will be required to deliver products to specified locations as indicated by the Department of Defence. Details about distribution points and delivery deadlines will be provided post-award.
Contact Information
For any inquiries related to this tender, bidders can reach out to the issuing authority through their official communication channels provided in the tender documentation. It is advisable to clarify any doubts before bid submission to ensure compliance with the tender requirements.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
4 DocumentsDocuments Required from Seller
- Experience Criteria
- Past Performance
- Bidder Turnover
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- OEM Annual Turnover
- Additional Doc 1 (Requested in ATC)
- Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity with valid licenses for pharmaceutical supply. Bidders must also comply with all applicable regulatory standards. Additionally, they need to demonstrate financial stability and meet minimum technical specifications laid out by the Department of Defence for the Tab Dutasteride 0.5 mg supply.
Bidders are expected to provide specific certificates that validate their compliance with quality standards and testing criteria for pharmaceutical products. This includes certifications from recognized health authorities confirming the quality and safety of Tab Dutasteride 0.5 mg, along with any other documents that fulfill the eligibility and regulatory requirements.
Submissions must be made electronically through the designated e-procurement portal. Bidders are required to ensure their documents are submitted in the accepted formats, typically PDF or other specified file types. Following submission, it is important to keep track of confirmation receipts for reference during the process.
The evaluation and selection process will consider multiple factors, including compliance with technical specifications, price offerings, quality assurance measures, and the bidder’s previous performance records. The Department of Defence aims to ensure that the selected suppliers provide value and quality in the delivery of Tab Dutasteride 0.5 mg.
Micro, Small, and Medium Enterprises (MSEs) are encouraged to participate in this tender and may benefit from certain provisions intended to enhance their competitiveness. This includes support for compliance with local content and procurement rules, easier access to documents during the tender process, and possible assistance in fulfilling Make in India compliance requirements.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders